Maternal Use of Selective Serotonin Reuptake Inhibitors, Fetal Growth, and Risk of Adverse Birth Outcomes

Selective serotonin reuptake inhibitors (SSRIs) are frequently prescribed to pregnant women, but knowledge about their unintended effects on child health is scarce.To examine the effects of maternal SSRI use during pregnancy on fetal growth and birth outcomes.The study was embedded in the Generation R Study, a prospective population-based study from fetal life onward.Seven thousand six hundred ninety-six pregnant women were included. Selective...